Status:
COMPLETED
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology
Lead Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions:
Cancer
Solid Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multicenter, interventional, non-pharmacological study on a app for oral anticancer therapy management. A total of 124 patients will be considered. Patients will be randomized 1:1 to one o...
Detailed Description
This is a multicenter, interventional, non-pharmacological study on a app for oral anticancer therapy management. The primary aim of the study is to assess the effectiveness of the electronic diary i...
Eligibility Criteria
Inclusion
- ≥ 18 years old (both genders)
- Eastern Cooperative Oncology Group (ECOG) ≤2
- Patients with solid and haematological neoplasia (adjuvant or advanced setting) candidates to treatment with oral therapy.
Exclusion
- Patients who also receive anticancer treatment intravenously, as such patients access the hospital regularly and are in closer contact with healthcare personnel.
- Patients receiving experimental cancer treatment
- Patients who are unable to cooperate with study procedures (in the researcher's opinion)
- Patients who are candidates for oral drug treatment lasting less than 3 months.
- Patients with a life expectancy \<12 weeks.
- All patients being treated with drugs not listed in the Protocol Appendix C.
Key Trial Info
Start Date :
May 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2025
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04826458
Start Date
May 4 2021
End Date
November 11 2025
Last Update
December 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Irst Irccs
Meldola, FC, Italy, 47014
2
Ospedale Civile Santa Chiara di Trento
Trento, Italy, 38122